Donecopride is a dual-acting small molecule functioning as a 5-HT4 receptor partial agonist and a selective AChE inhibitor. It promotes sAPP-alpha release in vitro and demonstrates in vivo efficacy in Alzheimers disease mouse models by reducing amyloid-beta levels and improving cognitive performance in behavioral tests like NOR and Y-maze.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
